Study design and population:
Between July 2020 and October 2021, 8 patients underwent concomitant
Anaortic OPCAB and transfemoral TAVR during the same anesthetic. All
patients had severe aortic stenosis noted on pre-operative
echocardiographic evaluation, as defined by the AHA guidelines, and
concomitant coronary disease that was considered not amenable to PCI.
Furthermore, significant aortic calcification and atheromatous disease
were also seen in all 8 patients with all patients being diagnosed with
a porcelain aorta prior to surgical intervention (Table 1). Patients
were evaluated by the institutional, multidisciplinary structural heart
team including cardiac surgeons, imaging and interventional
cardiologists. Once approved, the patients were scheduled for
concomitant anaortic OPCAB and TAVR.